SE9303068D0 - New use - Google Patents
New useInfo
- Publication number
- SE9303068D0 SE9303068D0 SE9303068A SE9303068A SE9303068D0 SE 9303068 D0 SE9303068 D0 SE 9303068D0 SE 9303068 A SE9303068 A SE 9303068A SE 9303068 A SE9303068 A SE 9303068A SE 9303068 D0 SE9303068 D0 SE 9303068D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- date
- sec
- patient
- treatment
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 abstract 2
- 108010051696 Growth Hormone Proteins 0.000 abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- 239000000122 growth hormone Substances 0.000 abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 abstract 1
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 abstract 1
- 102000013275 Somatomedins Human genes 0.000 abstract 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
PT94928538T PT720483E (pt) | 1993-09-21 | 1994-09-21 | Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demencia |
ES94928538T ES2218529T3 (es) | 1993-09-21 | 1994-09-21 | Uso de la hormona del crecimiento para la produccion de un medicamento para el tratamiento de lesiones isquemicas en el cerebro y demencia. |
NZ274025A NZ274025A (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasing the concentration of GH in cerebrospinal fluid |
DK94928538T DK0720483T3 (da) | 1993-09-21 | 1994-09-21 | Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens |
JP7509721A JPH09502973A (ja) | 1993-09-21 | 1994-09-21 | 脳脊髄液中のgh,igf−▲i▼およびigfbp−3の濃度の増加のために用いる成長ホルモン |
CA002168570A CA2168570C (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
AT94928538T ATE263573T1 (de) | 1993-09-21 | 1994-09-21 | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz |
DE69433687T DE69433687T2 (de) | 1993-09-21 | 1994-09-21 | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz |
EP94928538A EP0720483B1 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone in the manufacture of a medicament for the treatment of ischaemic brain damage and dementia |
AU77933/94A AU683306B2 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid |
US08/602,728 US5736515A (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid |
PCT/SE1994/000875 WO1995008345A1 (en) | 1993-09-21 | 1994-09-21 | Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9303068D0 true SE9303068D0 (sv) | 1993-09-21 |
Family
ID=20391162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
Country Status (13)
Country | Link |
---|---|
US (1) | US5736515A (sv) |
EP (1) | EP0720483B1 (sv) |
JP (1) | JPH09502973A (sv) |
AT (1) | ATE263573T1 (sv) |
AU (1) | AU683306B2 (sv) |
CA (1) | CA2168570C (sv) |
DE (1) | DE69433687T2 (sv) |
DK (1) | DK0720483T3 (sv) |
ES (1) | ES2218529T3 (sv) |
NZ (1) | NZ274025A (sv) |
PT (1) | PT720483E (sv) |
SE (1) | SE9303068D0 (sv) |
WO (1) | WO1995008345A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6514937B1 (en) | 1997-02-25 | 2003-02-04 | Celtrix Pharmaceuticals, Inc. | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
US6015786A (en) * | 1997-02-25 | 2000-01-18 | Celtrix Pharmaceuticals, Inc. | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
US6025368A (en) * | 1997-02-25 | 2000-02-15 | Celtrix Pharmaceuticals, Inc. | Method for treating the symptoms of chronic stress-related disorders using IGF |
WO2000013650A2 (en) | 1998-09-03 | 2000-03-16 | Neuronz Limited | Neuroprotection |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
MXPA06000954A (es) * | 2003-07-29 | 2006-05-04 | Ares Trading Sa | Uso de hormona del crecimiento humano en atrofia de multiples sistemas. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2974088A (en) * | 1958-07-18 | 1961-03-07 | Merck & Co Inc | Method of preparing growth hormone |
US3118815A (en) * | 1959-09-28 | 1964-01-21 | Upjohn Co | Growth hormone and recovery thereof |
EP0103395A3 (en) * | 1982-08-17 | 1985-05-22 | Biogen N.V. | Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
US4521409A (en) * | 1983-10-03 | 1985-06-04 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance ruminant mammary development |
EP0210219B1 (en) * | 1985-01-28 | 1989-04-12 | PARK, Seung Moon | Lighting apparatus for wheels of vehicles |
US4670249A (en) * | 1985-04-12 | 1987-06-02 | International Minerals & Chemical Corp. | Growth-promoting compositions |
US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
IL79681A (en) * | 1985-08-12 | 1991-06-10 | Int Minerals & Chem Corp | Transition metal complexes of growth hormones and their prolonged release compositions |
ZA866218B (en) * | 1985-08-23 | 1988-03-30 | Lilly Co Eli | Injectable sustained release formulation |
US4977140A (en) * | 1985-08-23 | 1990-12-11 | Eli Lilly And Company | Injectable sustained release formulation |
US4857506A (en) * | 1987-01-12 | 1989-08-15 | American Cyanamid Company | Sustained release growth hormone compositions for parenteral administration and their use |
US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
NZ223842A (en) * | 1988-03-10 | 1991-07-26 | Amgen Inc | Porcine growth hormone analogues, production using genetic engineering and compositions for promoting growth in mammals |
-
1993
- 1993-09-21 SE SE9303068A patent/SE9303068D0/sv unknown
-
1994
- 1994-09-21 NZ NZ274025A patent/NZ274025A/en not_active IP Right Cessation
- 1994-09-21 PT PT94928538T patent/PT720483E/pt unknown
- 1994-09-21 CA CA002168570A patent/CA2168570C/en not_active Expired - Fee Related
- 1994-09-21 DE DE69433687T patent/DE69433687T2/de not_active Expired - Lifetime
- 1994-09-21 DK DK94928538T patent/DK0720483T3/da active
- 1994-09-21 JP JP7509721A patent/JPH09502973A/ja active Pending
- 1994-09-21 AT AT94928538T patent/ATE263573T1/de active
- 1994-09-21 EP EP94928538A patent/EP0720483B1/en not_active Expired - Lifetime
- 1994-09-21 ES ES94928538T patent/ES2218529T3/es not_active Expired - Lifetime
- 1994-09-21 US US08/602,728 patent/US5736515A/en not_active Expired - Lifetime
- 1994-09-21 WO PCT/SE1994/000875 patent/WO1995008345A1/en active IP Right Grant
- 1994-09-21 AU AU77933/94A patent/AU683306B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0720483A1 (en) | 1996-07-10 |
CA2168570C (en) | 2009-04-07 |
ATE263573T1 (de) | 2004-04-15 |
JPH09502973A (ja) | 1997-03-25 |
DE69433687T2 (de) | 2005-03-17 |
US5736515A (en) | 1998-04-07 |
EP0720483B1 (en) | 2004-04-07 |
DE69433687D1 (de) | 2004-05-13 |
ES2218529T3 (es) | 2004-11-16 |
WO1995008345A1 (en) | 1995-03-30 |
PT720483E (pt) | 2004-08-31 |
AU683306B2 (en) | 1997-11-06 |
AU7793394A (en) | 1995-04-10 |
DK0720483T3 (da) | 2004-08-09 |
CA2168570A1 (en) | 1995-03-30 |
NZ274025A (en) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
RU94046291A (ru) | Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i | |
ES2140463T3 (es) | Prevencion y tratamiento de la neuropatia periferica. | |
DE69121715T2 (de) | Die kombination des wachshormons und des insulin-ähnlichen wachstumsfaktors-i stimuliert das wachstum | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ATE288444T1 (de) | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren | |
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
DK0790824T3 (da) | 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens | |
NO940180D0 (no) | Anvendelse av IGF-I | |
DE69316013T2 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
SE9303068D0 (sv) | New use | |
CA2074166A1 (en) | Method for treating intestinal diseases | |
ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
DE69332541D1 (de) | Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie | |
DE69231036T2 (de) | Verfahren zur behandlung von patienten mit chronischer lebererkrankung | |
DE69023006D1 (de) | Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen. | |
DE69427116T2 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
ATE107165T1 (de) | Verwendung von macrolactonen als antiallergica. | |
SE9002731D0 (sv) | Product comprising growth factor | |
DE69315840D1 (de) | Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor | |
DE69220229T2 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
MX9710291A (es) | Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos. |